首页 > 最新文献

Vestnik oftalmologii最新文献

英文 中文
[Progressive outer retinal necrosis caused by varicella zoster virus]. [水痘带状疱疹病毒引起进行性视网膜外坏死]。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma202514101199
A M Ryumin, A A Pavlova, D M Sobchak, I A Otmahova

Ophthalmic herpes zoster is the second most common form of herpes zoster and can lead to complete vision loss. Since necrotizing herpetic retinopathies are relatively rare and often reported as isolated clinical cases, establishing a unified approach to managing such patients is challenging. The aim of this study was to summarize current knowledge on the etiopathogenesis, diagnostic features, and treatment of progressive outer retinal necrosis. A total of 30 articles published in peer-reviewed journals between 2011 and 2019 and accessible through the EBSCO database were analyzed. The search employed relevant keywords and abbreviations: varicella zoster virus (VZV), herpes zoster ophthalmicus (HZO), necrotizing herpetic retinopathies (NHRs), and progressive outer retinal necrosis (PORN). The results of this analysis present the current understanding of the prevalence, clinical features, and management strategies for progressive outer retinal necrosis caused by VZV.

眼部带状疱疹是第二常见的带状疱疹,可导致完全失明。由于坏死性疱疹性视网膜病变相对罕见,通常作为孤立的临床病例报道,建立统一的方法来管理这类患者是具有挑战性的。本研究的目的是总结目前关于进展性视网膜外坏死的发病机制、诊断特征和治疗的知识。研究人员分析了2011年至2019年间发表在同行评议期刊上的30篇文章,这些文章可通过EBSCO数据库访问。检索使用相关关键词及缩略语:水痘带状疱疹病毒(VZV)、眼带状疱疹(HZO)、坏死性疱疹性视网膜病变(nhr)、进行性视网膜外坏死(PORN)。本分析的结果提出了目前对VZV引起的进行性视网膜外坏死的患病率、临床特征和治疗策略的理解。
{"title":"[Progressive outer retinal necrosis caused by varicella zoster virus].","authors":"A M Ryumin, A A Pavlova, D M Sobchak, I A Otmahova","doi":"10.17116/oftalma202514101199","DOIUrl":"10.17116/oftalma202514101199","url":null,"abstract":"<p><p>Ophthalmic herpes zoster is the second most common form of herpes zoster and can lead to complete vision loss. Since necrotizing herpetic retinopathies are relatively rare and often reported as isolated clinical cases, establishing a unified approach to managing such patients is challenging. The aim of this study was to summarize current knowledge on the etiopathogenesis, diagnostic features, and treatment of progressive outer retinal necrosis. A total of 30 articles published in peer-reviewed journals between 2011 and 2019 and accessible through the EBSCO database were analyzed. The search employed relevant keywords and abbreviations: varicella zoster virus (VZV), herpes zoster ophthalmicus (HZO), necrotizing herpetic retinopathies (NHRs), and progressive outer retinal necrosis (PORN). The results of this analysis present the current understanding of the prevalence, clinical features, and management strategies for progressive outer retinal necrosis caused by VZV.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 1","pages":"99-103"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Artificial intelligence in assessment of individual risks of age-related macular degeneration progression]. [人工智能在年龄相关性黄斑变性进展个体风险评估中的应用]。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma2025141021123
Yu Yusef, A A Plyukhova, N Yusef

Age-related macular degeneration (AMD) is a progressive degenerative retinal disease and a leading cause of blindness in older adults worldwide. According to numerous studies, the number of affected individuals reached 196 million in 2020, with projections estimating an increase to 288 million by 2040, including 18.6 million cases of advanced AMD. The advent of optical coherence tomography (OCT) has enabled researchers and clinicians to characterize microstructural changes in different retinal layers at earlier disease stages and improve monitoring strategies. Important steps have been taken to develop algorithms capable of recognizing early signs of AMD, assessing its severity, and predicting progression. These algorithms have formed the basis for artificial intelligence (AI)-driven systems applicable to any hardware or software exhibiting intelligent behavior. OCT imaging allows for the identification of biomarkers whose presence or interaction with other factors predict transition from intermediate to advanced AMD. The obtained data can provide deeper insights into the pathogenesis of intermediate AMD, enhance early diagnosis for timely intervention, and facilitate the search for new treatment options. Artificial intelligence could make this process easier, simpler, less time-consuming, and more accurate by integrating structural OCT data with genetic risk indicators and lifestyle characteristics. However, the results are still inconsistent due to factors leading to limited result reliability, such as database quality, sample sizes, and data acquisition methods.

年龄相关性黄斑变性(AMD)是一种进行性退行性视网膜疾病,是全世界老年人失明的主要原因。根据大量研究,到2020年,受影响的个体数量达到1.96亿,预计到2040年将增加到2.88亿,其中包括1860万晚期AMD病例。光学相干断层扫描(OCT)的出现使研究人员和临床医生能够在疾病早期描述不同视网膜层的微观结构变化,并改进监测策略。在开发能够识别AMD早期症状、评估其严重程度和预测病情进展的算法方面,已经迈出了重要的一步。这些算法构成了人工智能(AI)驱动系统的基础,适用于任何表现出智能行为的硬件或软件。OCT成像允许识别生物标志物,其存在或与其他因素的相互作用可以预测从中度到晚期AMD的转变。获得的数据可以更深入地了解中期AMD的发病机制,增强早期诊断和及时干预,并促进寻找新的治疗方案。人工智能可以通过将结构OCT数据与遗传风险指标和生活方式特征相结合,使这一过程更容易、更简单、更省时、更准确。然而,由于数据库质量、样本量和数据采集方法等因素导致结果可靠性有限,结果仍然不一致。
{"title":"[Artificial intelligence in assessment of individual risks of age-related macular degeneration progression].","authors":"Yu Yusef, A A Plyukhova, N Yusef","doi":"10.17116/oftalma2025141021123","DOIUrl":"https://doi.org/10.17116/oftalma2025141021123","url":null,"abstract":"<p><p>Age-related macular degeneration (AMD) is a progressive degenerative retinal disease and a leading cause of blindness in older adults worldwide. According to numerous studies, the number of affected individuals reached 196 million in 2020, with projections estimating an increase to 288 million by 2040, including 18.6 million cases of advanced AMD. The advent of optical coherence tomography (OCT) has enabled researchers and clinicians to characterize microstructural changes in different retinal layers at earlier disease stages and improve monitoring strategies. Important steps have been taken to develop algorithms capable of recognizing early signs of AMD, assessing its severity, and predicting progression. These algorithms have formed the basis for artificial intelligence (AI)-driven systems applicable to any hardware or software exhibiting intelligent behavior. OCT imaging allows for the identification of biomarkers whose presence or interaction with other factors predict transition from intermediate to advanced AMD. The obtained data can provide deeper insights into the pathogenesis of intermediate AMD, enhance early diagnosis for timely intervention, and facilitate the search for new treatment options. Artificial intelligence could make this process easier, simpler, less time-consuming, and more accurate by integrating structural OCT data with genetic risk indicators and lifestyle characteristics. However, the results are still inconsistent due to factors leading to limited result reliability, such as database quality, sample sizes, and data acquisition methods.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 2","pages":"123-128"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144001074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The effects of intraoperative use of angiogenesis inhibitors on outcomes and complication rates in the surgical treatment of proliferative diabetic retinopathy]. 术中使用血管生成抑制剂对增殖性糖尿病视网膜病变手术治疗结果和并发症发生率的影响。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma202514102144
D V Petrachkov, V M Filippov, S Sh Balkar

Treatment of proliferative diabetic retinopathy (PDR) complications, such as vitreous haemorrhage and tractional retinal detachment, as well as macular involvement, remains a complex multifactorial challenge. The use of angiogenesis inhibitors (AIs) at different stages of patient management is being investigated. In particular, intraoperative use of AIs appears to be pathogenetically justified.

Purpose: This study evaluates the effect of intraoperative administration of AIs on the outcomes and complication rates in the surgical treatment of PDR.

Material and methods: A comparative analysis of anatomical and functional outcomes, as well as postoperative complication rates, was performed in two comparable groups of patients who underwent surgery for PDR complications: one with intraoperative AI use (60 cases, 60 eyes), and one without it (109 cases, 109 eyes). The evaluation was conducted at the early (1 month) and long-term (6 months) postoperative follow-ups.

Results: The use of AIs was significantly correlated with higher postoperative visual acuity at all follow-up periods and with lower central retinal thickness (CRT) at 1 month after surgery. The complication rate was numerically higher in the group without AIs use, with borderline statistical significance noted for vitreous hemorrhage and anterior segment neovascularization (p=0.079 and p=0.096, respectively). No statistically significant differences were observed between the groups in the incidence of diabetic macular edema (DME) or cases of vitreous hemorrhage requiring revision surgery.

Conclusion: Given the high variability in clinical presentation of PDR, the use of AIs at different stages of treatment is justified. The study provides promising insights into the effects of intraoperative AIs administration on anatomical and functional outcomes, as well as complication rates. Further research into AIs effects taking into account the cytokine profile may be relevant for the personalized selection of treatment strategies.

增殖性糖尿病视网膜病变(PDR)并发症的治疗,如玻璃体出血和牵引性视网膜脱离,以及黄斑受累,仍然是一个复杂的多因素挑战。血管生成抑制剂(AIs)在患者管理的不同阶段的使用正在研究中。特别是,术中使用人工智能似乎是病理合理的。目的:探讨术中给药对PDR手术治疗结局及并发症发生率的影响。材料和方法:对两组因PDR并发症接受手术的患者进行解剖和功能结果以及术后并发症发生率的比较分析:一组患者术中使用人工智能(60例,60眼),一组患者未使用人工智能(109例,109眼)。在术后早期(1个月)和长期(6个月)随访时进行评估。结果:AIs的使用与术后随访期间较高的术后视力和术后1个月较低的视网膜中央厚度(CRT)显著相关。未使用人工智能系统组的并发症发生率在数字上更高,玻璃体出血和前段新生血管的发生率有临界统计学意义(p=0.079和p=0.096)。两组间糖尿病性黄斑水肿(DME)或玻璃体出血需要翻修手术的发生率无统计学差异。结论:鉴于PDR临床表现的高度可变性,在不同治疗阶段使用ai是合理的。该研究为术中给药人工智能对解剖和功能结果以及并发症发生率的影响提供了有希望的见解。考虑到细胞因子特征,进一步研究AIs效应可能与个性化治疗策略的选择有关。
{"title":"[The effects of intraoperative use of angiogenesis inhibitors on outcomes and complication rates in the surgical treatment of proliferative diabetic retinopathy].","authors":"D V Petrachkov, V M Filippov, S Sh Balkar","doi":"10.17116/oftalma202514102144","DOIUrl":"https://doi.org/10.17116/oftalma202514102144","url":null,"abstract":"<p><p>Treatment of proliferative diabetic retinopathy (PDR) complications, such as vitreous haemorrhage and tractional retinal detachment, as well as macular involvement, remains a complex multifactorial challenge. The use of angiogenesis inhibitors (AIs) at different stages of patient management is being investigated. In particular, intraoperative use of AIs appears to be pathogenetically justified.</p><p><strong>Purpose: </strong>This study evaluates the effect of intraoperative administration of AIs on the outcomes and complication rates in the surgical treatment of PDR.</p><p><strong>Material and methods: </strong>A comparative analysis of anatomical and functional outcomes, as well as postoperative complication rates, was performed in two comparable groups of patients who underwent surgery for PDR complications: one with intraoperative AI use (60 cases, 60 eyes), and one without it (109 cases, 109 eyes). The evaluation was conducted at the early (1 month) and long-term (6 months) postoperative follow-ups.</p><p><strong>Results: </strong>The use of AIs was significantly correlated with higher postoperative visual acuity at all follow-up periods and with lower central retinal thickness (CRT) at 1 month after surgery. The complication rate was numerically higher in the group without AIs use, with borderline statistical significance noted for vitreous hemorrhage and anterior segment neovascularization (<i>p</i>=0.079 and <i>p</i>=0.096, respectively). No statistically significant differences were observed between the groups in the incidence of diabetic macular edema (DME) or cases of vitreous hemorrhage requiring revision surgery.</p><p><strong>Conclusion: </strong>Given the high variability in clinical presentation of PDR, the use of AIs at different stages of treatment is justified. The study provides promising insights into the effects of intraoperative AIs administration on anatomical and functional outcomes, as well as complication rates. Further research into AIs effects taking into account the cytokine profile may be relevant for the personalized selection of treatment strategies.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 2","pages":"44-50"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144039721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Microbiota of the ocular surface in children with myopia]. [近视儿童眼表微生物群]。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma20251410315
O I Orenburkina, G N Rezbaeva, V V Dudurich, A E Babushkin, K S Sogomonian, A A Danilova, L G Danilov

A healthy ocular surface is characterized by relatively stable and comparatively low microbial diversity. However, pathological conditions can provoke shifts in the composition of bacterial taxa, which may be associated, among other factors, with the progression of myopia.

Purpose: This study compared the taxonomic diversity of the conjunctival microbiota in children with varying degrees of myopia and those without clinically confirmed myopia.

Material and methods: Ocular surface samples were obtained from 29 children aged 6-17 years with myopia (58 eyes) and from 12 children of the control group aged 9-17 years (24 eyes). The taxonomic composition of the conjunctival microbiota was analyzed using 16S ribosomal RNA gene (rRNA) sequencing, followed by microbiome profiling through bioinformatics and statistical tools.

Results: The ocular surface microbiota in children with myopia demonstrated higher alpha diversity compared to the control group. This was confirmed by values of the Chao (reflecting low-abundance taxa) and Shannon (reflecting overall bacterial diversity - higher diversity means higher index; optimal value; 3.1-4.2) indices. The results revealed a clear trend toward differentiation in bacterial composition between myopic and control groups. These differences were associated with changes in the relative abundance of opportunistic bacteria depending on the degree of myopia.

Conclusion: The taxonomic diversity of the ocular microbiota at the genus level in patients with varying degrees of myopia was characterized by a higher number of taxonomic units compared to the control group. The general trend is an increase in the biodiversity of the bacterial composition due to an increase in the relative representation of opportunistic microorganisms. Further research on the influence of the ocular microbiota on the progression of myopia is needed.

健康的眼表具有相对稳定和相对较低的微生物多样性。然而,病理条件可以引起细菌类群组成的变化,这可能与其他因素有关,与近视的进展有关。目的:本研究比较了不同程度近视儿童和临床未确诊近视儿童结膜微生物群的分类学多样性。材料与方法:选取6-17岁近视儿童29例(58眼)和对照组9-17岁儿童12例(24眼)的眼表样本。使用16S核糖体RNA基因(rRNA)测序分析结膜微生物群的分类组成,然后通过生物信息学和统计工具进行微生物组分析。结果:与对照组相比,近视儿童的眼表微生物群具有更高的α多样性。Chao(反映低丰度分类群)和Shannon(反映整体细菌多样性)的值证实了这一点,多样性越高,指数越高;最优值;3.1 - -4.2)指数。结果显示近视组和对照组之间细菌组成有明显的分化趋势。这些差异与机会性细菌相对丰度的变化有关,这取决于近视程度。结论:不同程度近视患者的眼微生物群在属水平上的分类多样性比对照组有更多的分类单位。总的趋势是,由于机会微生物的相对代表性增加,细菌组成的生物多样性增加。眼部微生物群对近视发展的影响有待进一步研究。
{"title":"[Microbiota of the ocular surface in children with myopia].","authors":"O I Orenburkina, G N Rezbaeva, V V Dudurich, A E Babushkin, K S Sogomonian, A A Danilova, L G Danilov","doi":"10.17116/oftalma20251410315","DOIUrl":"https://doi.org/10.17116/oftalma20251410315","url":null,"abstract":"<p><p>A healthy ocular surface is characterized by relatively stable and comparatively low microbial diversity. However, pathological conditions can provoke shifts in the composition of bacterial taxa, which may be associated, among other factors, with the progression of myopia.</p><p><strong>Purpose: </strong>This study compared the taxonomic diversity of the conjunctival microbiota in children with varying degrees of myopia and those without clinically confirmed myopia.</p><p><strong>Material and methods: </strong>Ocular surface samples were obtained from 29 children aged 6-17 years with myopia (58 eyes) and from 12 children of the control group aged 9-17 years (24 eyes). The taxonomic composition of the conjunctival microbiota was analyzed using 16S ribosomal RNA gene (rRNA) sequencing, followed by microbiome profiling through bioinformatics and statistical tools.</p><p><strong>Results: </strong>The ocular surface microbiota in children with myopia demonstrated higher alpha diversity compared to the control group. This was confirmed by values of the Chao (reflecting low-abundance taxa) and Shannon (reflecting overall bacterial diversity - higher diversity means higher index; optimal value; 3.1-4.2) indices. The results revealed a clear trend toward differentiation in bacterial composition between myopic and control groups. These differences were associated with changes in the relative abundance of opportunistic bacteria depending on the degree of myopia.</p><p><strong>Conclusion: </strong>The taxonomic diversity of the ocular microbiota at the genus level in patients with varying degrees of myopia was characterized by a higher number of taxonomic units compared to the control group. The general trend is an increase in the biodiversity of the bacterial composition due to an increase in the relative representation of opportunistic microorganisms. Further research on the influence of the ocular microbiota on the progression of myopia is needed.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 3","pages":"5-12"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144545013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Use of ozone therapy in the treatment of complications following penetrating keratoplasty for rosacea-associated keratitis]. 臭氧治疗穿透性角膜移植术治疗酒渣鼻相关性角膜炎并发症的应用
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma202514104166
A M Bystrov, E V Davydova, A A Kuznetzov, M S Sumina

Rosacea is a chronic inflammatory dermatosis, one manifestation of which involves pathological processes in various ocular structures. The most severe form is rosacea-associated keratitis. Given the multifactorial etiology and pathogenesis, this condition remains unpredictable and resistant to treatment. This study presents a clinical case of using ozone therapy in the management of complications following penetrating keratoplasty in the setting of rosacea-associated keratitis and demonstrates the therapeutic effectiveness of ozone therapy as part of a comprehensive approach to managing post-keratoplasty complications in patients with rosacea-associated keratitis. The inclusion of ozone therapy led to clinical and functional improvement by day 10. By day 60, corneal syndrome manifestations were minimal, the graft remained transparent, and significant regression of neovascularization was observed. Due to the pronounced anti-inflammatory and reparative effects of therapeutic ozone concentrations, its use in this context is pathogenetically justified.

酒渣鼻是一种慢性炎症性皮肤病,其表现之一涉及多种眼部结构的病理过程。最严重的形式是酒渣鼻相关性角膜炎。鉴于多因素的病因和发病机制,这种情况仍然是不可预测的和耐药的治疗。本研究报告了一个应用臭氧治疗治疗酒渣鼻相关性角膜炎穿透性角膜移植术后并发症的临床病例,并证明了臭氧治疗作为治疗酒渣鼻相关性角膜炎患者角膜移植术后并发症的综合方法的一部分的治疗效果。纳入臭氧治疗后第10天临床和功能改善。到第60天,角膜综合征的表现最小,移植物保持透明,观察到新生血管明显消退。由于治疗性臭氧浓度具有明显的抗炎和修复作用,因此在这种情况下使用它在病理学上是合理的。
{"title":"[Use of ozone therapy in the treatment of complications following penetrating keratoplasty for rosacea-associated keratitis].","authors":"A M Bystrov, E V Davydova, A A Kuznetzov, M S Sumina","doi":"10.17116/oftalma202514104166","DOIUrl":"10.17116/oftalma202514104166","url":null,"abstract":"<p><p>Rosacea is a chronic inflammatory dermatosis, one manifestation of which involves pathological processes in various ocular structures. The most severe form is rosacea-associated keratitis. Given the multifactorial etiology and pathogenesis, this condition remains unpredictable and resistant to treatment. This study presents a clinical case of using ozone therapy in the management of complications following penetrating keratoplasty in the setting of rosacea-associated keratitis and demonstrates the therapeutic effectiveness of ozone therapy as part of a comprehensive approach to managing post-keratoplasty complications in patients with rosacea-associated keratitis. The inclusion of ozone therapy led to clinical and functional improvement by day 10. By day 60, corneal syndrome manifestations were minimal, the graft remained transparent, and significant regression of neovascularization was observed. Due to the pronounced anti-inflammatory and reparative effects of therapeutic ozone concentrations, its use in this context is pathogenetically justified.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 4","pages":"66-72"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145016241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Diffuse lamellar keratitis: sporadic and cluster forms]. 弥漫性板层性角膜炎:散发性和聚集性。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma202514104134
V M Sheludchenko, Yu Yusef, N V Sheludchenko, N V Slavinskaya

Diffuse lamellar keratitis (DLK) is a known complication of lamellar corneal surgery. The underlying mechanism of the cellular response in DLK is well described. There are two clinical forms - sporadic and cluster - each largely influenced by surgical triggers.

Objective: This study analyzes the incidence of different variants of DLK, identifies surgical causes, and outlines distinguishing features and preventive strategies.

Material and methods: The study included data from 19783 patients aged 18-45 years, among them 97% had myopia, and 3% had hyperopia. Patients in all examined cases underwent Laser-Assisted in Situ Keratomileusis (LASIK).

Results: The incidence of the sporadic form of DLK was 1:110, and the cluster form - 1:20. The main causes of cluster-form DLK were related to toxic surgical agents used in eyelid sanitation, keratomes, and medical gloves. Elimination of these factors stopped the progression of the cluster form. Sporadic DLK was associated with transient triggers disrupting the state of the interface. No DLK cases were recorded in patients undergoing hyperopia correction.

Conclusion: The primary surgical trigger for diffuse lamellar keratitis during LASIK is instability of the stromal interface resulting from improper flap repositioning, specific features of planar ablation, and exposure to toxic agents during surgery.

弥漫性板层角膜炎(DLK)是板层角膜手术的一种已知并发症。DLK细胞反应的潜在机制已被很好地描述。有两种临床形式-散发性和集群性-每一种主要受手术触发因素的影响。目的:本研究分析不同类型DLK的发病率,确定手术原因,并概述其特征和预防策略。材料与方法:研究纳入了19783例18-45岁的患者,其中97%为近视,3%为远视。所有病例均行激光辅助原位角膜磨砂术(LASIK)。结果:散发型DLK的发病率为1:10 0,聚集型DLK的发病率为- 1:20。造成丛集型DLK的主要原因与眼睑卫生、角膜肿和医用手套中使用的有毒手术剂有关。消除这些因素阻止了群集形式的发展。偶发DLK与中断接口状态的瞬态触发器有关。远视矫正患者无DLK病例。结论:LASIK手术中弥漫性板层角膜炎的主要手术触发因素是由于皮瓣复位不当、平面消融的特定特征以及术中暴露于有毒物质导致的间质界面不稳定。
{"title":"[Diffuse lamellar keratitis: sporadic and cluster forms].","authors":"V M Sheludchenko, Yu Yusef, N V Sheludchenko, N V Slavinskaya","doi":"10.17116/oftalma202514104134","DOIUrl":"https://doi.org/10.17116/oftalma202514104134","url":null,"abstract":"<p><p>Diffuse lamellar keratitis (DLK) is a known complication of lamellar corneal surgery. The underlying mechanism of the cellular response in DLK is well described. There are two clinical forms - sporadic and cluster - each largely influenced by surgical triggers.</p><p><strong>Objective: </strong>This study analyzes the incidence of different variants of DLK, identifies surgical causes, and outlines distinguishing features and preventive strategies.</p><p><strong>Material and methods: </strong>The study included data from 19783 patients aged 18-45 years, among them 97% had myopia, and 3% had hyperopia. Patients in all examined cases underwent Laser-Assisted in Situ Keratomileusis (LASIK).</p><p><strong>Results: </strong>The incidence of the sporadic form of DLK was 1:110, and the cluster form - 1:20. The main causes of cluster-form DLK were related to toxic surgical agents used in eyelid sanitation, keratomes, and medical gloves. Elimination of these factors stopped the progression of the cluster form. Sporadic DLK was associated with transient triggers disrupting the state of the interface. No DLK cases were recorded in patients undergoing hyperopia correction.</p><p><strong>Conclusion: </strong>The primary surgical trigger for diffuse lamellar keratitis during LASIK is instability of the stromal interface resulting from improper flap repositioning, specific features of planar ablation, and exposure to toxic agents during surgery.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 4","pages":"34-40"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145016304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Use of faricimab in neovascular age-related macular degeneration and diabetic macular edema in Russia. Results of the FARWATER retrospective study]. 法利昔单抗在俄罗斯新生血管性年龄相关性黄斑变性和糖尿病性黄斑水肿中的应用。FARWATER回顾性研究结果]。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma202514106182
N V Neroeva, A Zh Fursova, R R Faizrakhmanov, A A Plyukhova, E V Bobykin, M V Gordeeva, E V Karlova, E D Bosov, A A Nikiforova

Despite the positive outcomes of anti-VEGF therapy, neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) remain major medical and social challenges, and optimization of their treatment is an urgent need.

Purpose: This study evaluated the effectiveness of Vabysmo (faricimab) in the treatment of patients with nAMD and DME in real-world clinical practice in Russia.

Material and methods: A multicenter retrospective analysis was conducted based on the medical records of 328 patients (370 eyes) with nAMD and 87 patients (112 eyes) with DME (both treatment-naïve and previously treated with anti-VEGF agents) who received faricimab from July 2023 to February 2025. The following primary effectiveness indicators were assessed: changes in visual acuity (VA) and central retinal thickness (CRT) after the first four faricimab injections. Secondary outcome indicators included changes in VA, CRT, and selected disease biomarkers at 6, 12, and 18 months of treatment, as well as injection intervals during the maintenance phase.

Results: After the first four consecutive faricimab injections, VA improved by 8.1 ETDRS letters (p<0.05) in the nAMD group and by 12.8 ETDRS letters (p<0.05) in the DME group. CRT decreased by 103.3 μm (p<0.05) and 177.4 μm (p<0.05), respectively. These improvements remained stable during further follow-up (8.78±4.51 months in the nAMD group and 10.48±5.24 months in the DME group, up to a maximum of 19 months in both groups). The proportion of patients who achieved injection intervals of ≥12 weeks was 27.9% in the nAMD group and 38.5% in the DME group.

Conclusion: Faricimab demonstrated high clinical effectiveness in real-world settings in patients with nAMD and DME, with the potential to reduce the treatment burden for patients and the healthcare system.

尽管抗vegf治疗有积极的结果,但新血管性年龄相关性黄斑变性(nAMD)和糖尿病性黄斑水肿(DME)仍然是主要的医学和社会挑战,迫切需要优化其治疗方法。目的:本研究评估Vabysmo (faricimab)在俄罗斯现实世界临床实践中治疗nAMD和DME患者的有效性。材料和方法:对2023年7月至2025年2月期间接受法利西单抗治疗的328例(370只眼)nAMD患者和87例(112只眼)DME患者(均为treatment-naïve,既往接受过抗vegf药物治疗)的病历进行多中心回顾性分析。评估以下主要有效性指标:前四次法利昔单抗注射后视力(VA)和视网膜中央厚度(CRT)的变化。次要结局指标包括治疗6个月、12个月和18个月时VA、CRT和选定疾病生物标志物的变化,以及维持期的注射间隔。结果:在前四次连续注射法利昔单抗后,VA提高了8.1个ETDRS字母(ppppp)。结论:法利昔单抗在现实环境中对nAMD和DME患者显示出很高的临床有效性,有可能减轻患者和医疗保健系统的治疗负担。
{"title":"[Use of faricimab in neovascular age-related macular degeneration and diabetic macular edema in Russia. Results of the FARWATER retrospective study].","authors":"N V Neroeva, A Zh Fursova, R R Faizrakhmanov, A A Plyukhova, E V Bobykin, M V Gordeeva, E V Karlova, E D Bosov, A A Nikiforova","doi":"10.17116/oftalma202514106182","DOIUrl":"10.17116/oftalma202514106182","url":null,"abstract":"<p><p>Despite the positive outcomes of anti-VEGF therapy, neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) remain major medical and social challenges, and optimization of their treatment is an urgent need.</p><p><strong>Purpose: </strong>This study evaluated the effectiveness of Vabysmo (faricimab) in the treatment of patients with nAMD and DME in real-world clinical practice in Russia.</p><p><strong>Material and methods: </strong>A multicenter retrospective analysis was conducted based on the medical records of 328 patients (370 eyes) with nAMD and 87 patients (112 eyes) with DME (both treatment-naïve and previously treated with anti-VEGF agents) who received faricimab from July 2023 to February 2025. The following primary effectiveness indicators were assessed: changes in visual acuity (VA) and central retinal thickness (CRT) after the first four faricimab injections. Secondary outcome indicators included changes in VA, CRT, and selected disease biomarkers at 6, 12, and 18 months of treatment, as well as injection intervals during the maintenance phase.</p><p><strong>Results: </strong>After the first four consecutive faricimab injections, VA improved by 8.1 ETDRS letters (<i>p</i><0.05) in the nAMD group and by 12.8 ETDRS letters (<i>p</i><0.05) in the DME group. CRT decreased by 103.3 μm (<i>p</i><0.05) and 177.4 μm (<i>p</i><0.05), respectively. These improvements remained stable during further follow-up (8.78±4.51 months in the nAMD group and 10.48±5.24 months in the DME group, up to a maximum of 19 months in both groups). The proportion of patients who achieved injection intervals of ≥12 weeks was 27.9% in the nAMD group and 38.5% in the DME group.</p><p><strong>Conclusion: </strong>Faricimab demonstrated high clinical effectiveness in real-world settings in patients with nAMD and DME, with the potential to reduce the treatment burden for patients and the healthcare system.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 6","pages":"82-91"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145811478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sarcopenic obesity and interleukin status in patients with age-associated pathology of the visual organ]. [年龄相关性视觉器官病变患者的肌少性肥胖和白细胞介素水平]。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma202514106122
A E Kopylov, N M Agarkov, A A Abramov

An increase in the content of pro-inflammatory cytokines in blood plasma in sarcopenic obesity (SO) is a predictor of progressive loss of muscle strength and is associated with an increased risk of disability and mortality in old age. To date, practically no studies has been conducted to address the characteristics of cytokine status in this category of patients with age-associated ophthalmic pathology.

Purpose: This study analyzed and evaluated the ratio of pro- and anti-inflammatory interleukin (IL) levels in blood plasma of elderly patients with sarcopenia/SO and cataract.

Material and methods: The study included 48 patients aged 60-74 years with SO and cataract (group 1) and 54 patients aged 60-74 years with sarcopenia and cataract (group 2) who underwent inpatient examination and treatment at the Tambov branch of the S.N. Fedorov National Medical Research Center "MNTK "Eye Microsurgery" in 2023-2024. Plasma levels of IL-1α, -1β, -4, -5, -6, -7, -8, -9, -10, -12, -17, and IL-18 were measured using flow cytometry. The control group included 32 patients aged 60-74 years without sarcopenia/SO and ophthalmic pathology.

Results: The study revealed that in elderly patients with cataract, a pronounced increase in pro-inflammatory and a decrease in anti-inflammatory IL plasma levels contributes to the transition from sarcopenia to SO. Plasma IL-6 levels in group 1 patients reached 22.3±2.0 pg/mL compared with 4.9±0.6 pg/mL in the control group (p<0.001). Development of SO in elderly patients with age-associated ocular pathology was also associated with an increase in IL-8 concentrations to 36.4±3.3 pg/mL and IL-17 to 20.5±1.6 pg/mL (p<0.001 for both). Plasma levels of anti-inflammatory ILs were significantly lower (p<0.01) in patients with SO and cataract: for IL-4 it was 2.1±0.2 pg/mL, for IL-10 - 9.4±0.4 pg/mL.

Conclusion: The identified features of comorbidity of age-associated ophthalmic pathology (cataract) and sarcopenic disorders may have certain clinical significance. In particular, the observed associations may provide a basis for developing recommendations by nutritionists/dietitians and ophthalmologists for these patients regarding dietary and lifestyle modifications.

肌减少性肥胖(SO)患者血浆中促炎细胞因子含量的增加是肌肉力量进行性丧失的一个预测指标,并与老年残疾和死亡风险的增加有关。迄今为止,几乎没有研究已经进行了解决细胞因子状态的特点,这类患者与年龄相关的眼部病理。目的:分析和评价老年骨骼肌减少症/SO合并白内障患者血浆中亲炎性与抗炎性白细胞介素(IL)的比值。材料与方法:研究纳入2023-2024年在费多罗夫国家医学研究中心“MNTK”眼显微外科坦波夫分院住院检查治疗的48例60-74岁SO合并白内障患者(第一组)和54例60-74岁肌少症合并白内障患者(第二组)。采用流式细胞术检测血浆中IL-1α、-1β、-4、-5、-6、-7、-8、-9、-10、-12、-17和IL-18的水平。对照组32例,年龄60 ~ 74岁,无肌少症/SO及眼部病理。结果:本研究发现,老年白内障患者血浆中促炎IL水平的显著升高和抗炎IL水平的显著降低有助于骨骼肌减少症向SO的转变。1组患者血浆IL-6水平为22.3±2.0 pg/mL,对照组为4.9±0.6 pg/mL (ppp)结论:年龄相关性眼科病变(白内障)和肌肉减少性疾病的合并症特征的确定可能具有一定的临床意义。特别是,观察到的关联可能为营养学家/营养师和眼科医生为这些患者提供关于饮食和生活方式改变的建议提供基础。
{"title":"[Sarcopenic obesity and interleukin status in patients with age-associated pathology of the visual organ].","authors":"A E Kopylov, N M Agarkov, A A Abramov","doi":"10.17116/oftalma202514106122","DOIUrl":"https://doi.org/10.17116/oftalma202514106122","url":null,"abstract":"<p><p>An increase in the content of pro-inflammatory cytokines in blood plasma in sarcopenic obesity (SO) is a predictor of progressive loss of muscle strength and is associated with an increased risk of disability and mortality in old age. To date, practically no studies has been conducted to address the characteristics of cytokine status in this category of patients with age-associated ophthalmic pathology.</p><p><strong>Purpose: </strong>This study analyzed and evaluated the ratio of pro- and anti-inflammatory interleukin (IL) levels in blood plasma of elderly patients with sarcopenia/SO and cataract.</p><p><strong>Material and methods: </strong>The study included 48 patients aged 60-74 years with SO and cataract (group 1) and 54 patients aged 60-74 years with sarcopenia and cataract (group 2) who underwent inpatient examination and treatment at the Tambov branch of the S.N. Fedorov National Medical Research Center \"MNTK \"Eye Microsurgery\" in 2023-2024. Plasma levels of IL-1α, -1β, -4, -5, -6, -7, -8, -9, -10, -12, -17, and IL-18 were measured using flow cytometry. The control group included 32 patients aged 60-74 years without sarcopenia/SO and ophthalmic pathology.</p><p><strong>Results: </strong>The study revealed that in elderly patients with cataract, a pronounced increase in pro-inflammatory and a decrease in anti-inflammatory IL plasma levels contributes to the transition from sarcopenia to SO. Plasma IL-6 levels in group 1 patients reached 22.3±2.0 pg/mL compared with 4.9±0.6 pg/mL in the control group (<i>p</i><0.001). Development of SO in elderly patients with age-associated ocular pathology was also associated with an increase in IL-8 concentrations to 36.4±3.3 pg/mL and IL-17 to 20.5±1.6 pg/mL (<i>p</i><0.001 for both). Plasma levels of anti-inflammatory ILs were significantly lower (<i>p</i><0.01) in patients with SO and cataract: for IL-4 it was 2.1±0.2 pg/mL, for IL-10 - 9.4±0.4 pg/mL.</p><p><strong>Conclusion: </strong>The identified features of comorbidity of age-associated ophthalmic pathology (cataract) and sarcopenic disorders may have certain clinical significance. In particular, the observed associations may provide a basis for developing recommendations by nutritionists/dietitians and ophthalmologists for these patients regarding dietary and lifestyle modifications.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 6","pages":"22-28"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145811425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tolosa-Hunt syndrome]. (Tolosa-Hunt综合症)。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma2025141061114
L V Reznikova, M B Kuchminskaya, L V Sherstneva, A E Aslamazova

Tolosa-Hunt syndrome (THS) is a rare neuro-ophthalmological pathology caused by nonspecific granulomatous inflammation in the area of the cavernous sinus, which leads to painful ocular motility restrictions and ophthalmoplegia. The disease is characterized by lesions of the III, IV, and VI cranial nerves, with possible extension to branches of the V nerve and oculosympathetic fibers. This review analyses current data on this disease, with emphasis on its clinical presentation, diagnostic criteria and treatment methods. Taking into account the complexity of identifying THS, emphasis is made on the need for careful differential diagnosis with other clinically similar conditions, such as brain tumors, vascular aneurysms, inflammatory processes, etc. Timely detection of the syndrome and initiation of appropriate treatment, including the use of glucocorticoid hormones, can help prevent serious complications in the form of vision loss or permanent impairment of ocular motor function.

托洛萨-亨特综合征(THS)是一种罕见的神经眼科病理,由海绵窦区域非特异性肉芽肿性炎症引起,可导致疼痛性眼球运动受限和眼麻痹。本病的特点是脑神经III、IV和VI的病变,并可能延伸到V神经的分支和眼交感神经纤维。本文综述了目前有关该病的资料,重点介绍了该病的临床表现、诊断标准和治疗方法。考虑到本病鉴别的复杂性,我们强调需要与其他临床类似的疾病进行仔细的鉴别诊断,如脑肿瘤、血管动脉瘤、炎症过程等。及时发现该综合征并开始适当治疗,包括使用糖皮质激素,可以帮助预防视力丧失或眼运动功能永久性损害等严重并发症。
{"title":"[Tolosa-Hunt syndrome].","authors":"L V Reznikova, M B Kuchminskaya, L V Sherstneva, A E Aslamazova","doi":"10.17116/oftalma2025141061114","DOIUrl":"https://doi.org/10.17116/oftalma2025141061114","url":null,"abstract":"<p><p>Tolosa-Hunt syndrome (THS) is a rare neuro-ophthalmological pathology caused by nonspecific granulomatous inflammation in the area of the cavernous sinus, which leads to painful ocular motility restrictions and ophthalmoplegia. The disease is characterized by lesions of the III, IV, and VI cranial nerves, with possible extension to branches of the V nerve and oculosympathetic fibers. This review analyses current data on this disease, with emphasis on its clinical presentation, diagnostic criteria and treatment methods. Taking into account the complexity of identifying THS, emphasis is made on the need for careful differential diagnosis with other clinically similar conditions, such as brain tumors, vascular aneurysms, inflammatory processes, etc. Timely detection of the syndrome and initiation of appropriate treatment, including the use of glucocorticoid hormones, can help prevent serious complications in the form of vision loss or permanent impairment of ocular motor function.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 6","pages":"114-118"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145811488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current view on the diagnosis of metamorphopsia in macular pathology]. 【黄斑病变中变形的诊断现状】。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.17116/oftalma202514105194
Yu Yusef, B A Telyatov, D V Petrachkov, I A Veliyeva, N A Fedoruk

This review addresses the current state of quantitative assessment of metamorphopsia. The article briefly describes the main symptoms of macular pathology as well as diseases associated with the development of metamorphopsia, defines the concept of metamorphopsia, and outlines different approaches to its classification. A substantial part of the review focuses on diagnostic methods for metamorphopsia, particularly the most widely used techniques for its quantitative evaluation. In addition, the work analyzes the main advantages and limitations inherent to these methods. It is substantiated that no optimal method for the quantitative assessment of metamorphopsia currently exists.

本文就变态的定量评价现状作一综述。本文简要介绍了黄斑病变的主要症状以及与变形相关的疾病,定义了变形的概念,并概述了其分类的不同方法。本综述的主要内容是对变态视症的诊断方法,特别是最常用的定量评价方法。此外,本文还分析了这些方法的主要优点和局限性。事实证明,目前还没有最优的方法来定量评价变态。
{"title":"[Current view on the diagnosis of metamorphopsia in macular pathology].","authors":"Yu Yusef, B A Telyatov, D V Petrachkov, I A Veliyeva, N A Fedoruk","doi":"10.17116/oftalma202514105194","DOIUrl":"https://doi.org/10.17116/oftalma202514105194","url":null,"abstract":"<p><p>This review addresses the current state of quantitative assessment of metamorphopsia. The article briefly describes the main symptoms of macular pathology as well as diseases associated with the development of metamorphopsia, defines the concept of metamorphopsia, and outlines different approaches to its classification. A substantial part of the review focuses on diagnostic methods for metamorphopsia, particularly the most widely used techniques for its quantitative evaluation. In addition, the work analyzes the main advantages and limitations inherent to these methods. It is substantiated that no optimal method for the quantitative assessment of metamorphopsia currently exists.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"141 5","pages":"94-100"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vestnik oftalmologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1